Desktop version

Home arrow Health arrow Cognitive enhancement : ethical and policy implications in international perspectives

Source

Acknowledgments

The author’s work is supported by the Medical Research Council of South Africa.

References

  • 1. Williams DR, Gonzalez HM, Williams S, Mohammed SA, Moomal H, Stein DJ. Perceived discrimination, race and health in South Africa. Soc Sci Med. 2008;67(3):441-452.
  • 2. Stein DJ. Psychiatric aspects of the Truth and Reconciliation Commission in South Africa. Brit J Psychiatry. 1998;173:455-457.
  • 3. Henrich J, Heine SJ, Norenzayan A. Most people are not WEIRD. Nature. 2010;466(7302):29.
  • 4. Stein DJ. Psychiatric contributions from South Africa: Ex Africa semper aliquid novi. Afr J Psychiatry. 2012;15(5):323-328.
  • 5. Stein DJ. Cosmetic psychopharmacology of anxiety: Bioethical considerations. Curr Psychiatry Rep. 2005;7(4):237-238.
  • 6. Verster GC, van Niekerk AA. Moral perspectives on stimulant use by healthy students.

South Afr Med J. 2012;102(12):909-911.

  • 7. Beyer C, Staunton C, Moodley K. The implications of methylphenidate use by healthy medical students and doctors in South Africa. BMC Med Ethics. 2014;15:20.
  • 8. Stein DJ. Philosophy of psychopharmacology. Perspect Biol Med. 1998;41(2):200-211.
  • 9. Stein DJ. Psychopharmacological enhancement: a conceptual framework. Philos Ethics HumanitMed: PEHM. 2012;7:5.
  • 10. Stein DJ. Philosophy of Psychopharmacology. Cambridge, UK: Cambridge University Press; 2008.
  • 11. Stein DJ. Philosophy and the DSM-III. Comp Psychiatry. 1991;32(5):404-415.
  • 12. Klerman GL. Psychotropic hedonism vs. pharmacological Calvinism. Hastings Cent Rep. 1972;2(4):1-3.
  • 13. President’s Council on Bioethics. Beyond Therapy: Biotechnology and the Pursuit of Happiness. Washington, DC: Author; 2003.
  • 14. Sandel MJ. The Case Against Perfection: Ethics in the Age of Genetic Engineering. Cambridge, MA: Harvard University Press; 2007.
  • 15. Shook JR, Giordano J. A principled and cosmopolitan neuroethics: Considerations for international relevance. Philos Ethics Humanit Med: PEHM. 2014;9:1.
  • 16. Greely H, Sahakian B, Harris J, et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature. 2008;456(7223):702-705.
  • 17. Sorsdahl K, Stein DJ, Grimsrud A, et al. Traditional healers in the treatment of common mental disorders in South Africa. J Nerv Ment Dis. 2009;197(6):434-441.
  • 18. Wudarczyk OA, Earp BD, Guastella A, Savulescu J. Could intranasal oxytocin be used to enhance relationships? Research imperatives, clinical policy, and ethical considerations. Curr Opin Psychiatry. 2013;26(5):474-484.
  • 19. Stein DJ. Positive mental health: A note of caution. World Psychiatry. 2012 ;11(2): 107-109.
  • 20. Prince M, Patel V, Saxena S, et al. No health without mental health. Lancet. 2007;370(9590):859-877.
  • 21. Stein DJ. A new mental health policy for South Africa. South Afr Med J. 2014;104(2):115-116.
  • 22. Patel V. Global mental health: From science to action. Harvard Rev Psychiatry. 2012;20(1):6-12.
  • 23. Stein DJ, He Y, Phillips A, Sahakian BJ, Williams J, Patel V. Global mental health and neuroscience: Potential synergies. Lancet Psychiatry. 2015;2(2):178-185.
  • 24. Insel TR, Quirion R. Psychiatry as a clinical neuroscience discipline. J Am Med Assn. 2005;294(17):2221-2224.
  • 25. Collins PY, Patel V, Joestl SS, et al. Grand challenges in global mental health. Nature. 2011;475(7354):27-30.
  • 26. Stein DJ. Is there a “mosquito net” for anxiety and mood disorders? Curr Psychiatry Rep. 2009;11(4):264-265.
 
Source
Found a mistake? Please highlight the word and press Shift + Enter  
< Prev   CONTENTS   Next >